mohd izzuan ResMed ( NYSE: RMD ) is up ~5% in after-hours trading after reporting Q3 financial results that beat on both lines. Non-GAAP net income rose 35% year-over-year to $325.4M.
Non-GAAP diluted earnings per share was $2.20 vs $1.64 in the year-ago period.
Also, non-GAAP.